Using hepatitis A and B vaccination as a paradigm for effective HIV vaccine delivery
Scott D. Rhodes A B C E and Leland J. Yee DA Section on Society and Health, Department of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest University Health Sciences, Medical Center Boulevard, Winston-Salem, NC 27157-1063, USA.
B Maya Angelou Research Center on Minority Health, Wake Forest University Health Sciences, Medical Center Boulevard, Winston-Salem, NC 27157-1063, USA.
C Section on Infectious Diseases, Department of Internal Medicine, Wake Forest University Health Sciences, Medical Center Boulevard, Winston-Salem, NC 27157-1063, USA.
D Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Pittsburgh, PA 15261, USA.
E Corresponding author. Email: srhodes@wfubmc.edu
Sexual Health 4(2) 121-127 https://doi.org/10.1071/SH06069
Submitted: 8 December 2006 Accepted: 26 April 2007 Published: 23 May 2007
Abstract
Background: An understanding of vaccine acceptance and uptake is imperative for successful vaccination of populations that will be primary targets for vaccination after a vaccine against HIV is developed and ready for dissemination. Experiences with vaccination against vaccine-preventable hepatitis (VPH) among men who have sex with men (MSM) may offer key insights to inform future HIV vaccination strategies. The purpose of this analysis was to explore what is known currently about vaccination among MSM, using knowledge gained from vaccination against VPH, and to identify important considerations from these experiences that must be explored further as a vaccine against HIV is promoted among MSM. Because cultural and political differences make it difficult to extrapolate findings from studies in one country to another, we have focused our analyses on studies conducted in the USA. Methods: Through a qualitative systematic review of published reports, we identified eight studies that reported correlates of VPH among MSM in the USA. Results: Six major domains of variables associated with vaccination against VPH were identified, including: demographics (e.g. younger age, higher educational attainment); increased vaccine knowledge; increased access to health care; provider recommendation; behaviours (e.g. same-sex behaviour, health-promoting and disease-preventing behaviours); and psychosocial factors (e.g. openness about one’s sexual orientation, reduced barriers to being vaccinated, self-efficacy). Conclusions: Further research is needed to understand vaccination behaviour among MSM and to maximise acceptance and uptake after a vaccine exists. Experiences with VPH provide a real-world model on which to base preliminary assumptions about acceptance and uptake of a vaccine against HIV.
Additional keywords: gay men, men who have sex with men, HIV/AIDS, USA.
Acknowledgements
LJY was supported by Grant # 1KL2 RR024154–01 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH.
[1] Sengupta S, Strauss RP, DeVellis R, Quinn SC, DeVellis B, Ware WB. Factors affecting African-American participation in AIDS research. J Acquir Immune Defic Syndr 2000; 24 275–84.
| PubMed |
[2] Sherr L, Bolding G, Elford J. Recruiting London gay men into an HIV vaccine trial: is it feasible? AIDS Care 2004; 16 565–71.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[3] Strauss RP, Sengupta S, Kegeles S, McLellan E, Metzger D, Eyre S, et al. Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities. J Acquir Immune Defic Syndr 2001; 26 63–71.
| PubMed |
[4] Buchbinder SP, Metch B, Holte SE, Scheer S, Coletti A, Vittinghoff E. Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. J Acquir Immune Defic Syndr 2004; 36 604–12.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[5] Harro CD, Judson FN, Gorse GJ, Mayer KH, Kostman JR, Brown SJ, et al. Recruitment and baseline epidemiologic profile of participants in the first Phase 3 HIV vaccine efficacy trial. J Acquir Immune Defic Syndr 2004; 37 1385–92.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[6] Suligoi B, Wagner TM, Ciccozzi M, Rezza G. The epidemiological contribution to the preparation of field trials for HIV and STI vaccines: objectives and methods of feasibility studies. Vaccine 2005; 23 1437–45.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[7] Crosby RA, Holtgrave DR, Bryant L, Frew PM. Factors associated with the acceptance of an AIDS vaccine: an exploratory study. Prev Med 2004; 39 804–8.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[8] Liau A, Zimet GD. The acceptability of HIV immunization: examining vaccine characteristics as determining factors. AIDS Care 2001; 13 643–50.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[9] Zimet GD, Liau A, Fortenberry VD. Health beliefs and intention to get immunized for HIV. J Adolesc Health 1997; 20 354–9.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[10] Liau A, Zimet GD. Undergraduates’ perception of HIV immunization: attitudes and behaviours as determining factors. Int J STD AIDS 2000; 11 445–50.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[11] Douglas JM, Judson FN, Parks JP, Buchbinder S, McKirnan D. Participation of homosexual/bisexual men in preventive HIV vaccine trials: baseline attitudes and concerns and predicted behaviors during trials. AIDS Res Hum Retroviruses 1994; 10 S257–60.
| PubMed |
[12] Hays RB, Kegeles SM. Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20 164–71.
| PubMed |
[13] Koblin BA, Avrett S, Taylor PE, Stevens CE. Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15 165–71.
| PubMed |
[14] Webb PM, Zimet GD, Mays R, Fortenberry JD. HIV immunization: acceptability and anticipated effects on sexual behavior among adolescents. J Adolesc Health 1999; 25 320–2.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[15] Koblin BA, Heagerty P, Sheon A, Buchbinder S, Celum C, Douglas JM, et al. Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States. AIDS 1998; 12 785–93.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[16] Newman PA, Duan N, Rudy ET, Roberts KJ, Swendeman D. Posttrial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk For HIV. J Acquir Immune Defic Syndr 2004; 37 1393–403.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[17] Newman PA, Duan N, Rudy ET, Johnston-Roberts K. HIV risk and prevention in a post-vaccine context. Vaccine 2004; 22 1954–63.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[18] Centers for Disease Control and Prevention Update on adult immunization recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1991; 40(RR-12): 1–52.
| PubMed |
[19] Centers for Disease Control and Prevention Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999; 48(RR-12): 1–37.
[20]
[21] MacKellar DA, Valleroy LA, Secura GM, McFarland W, Shehan D, Ford W, et al. Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men. Am J Public Health 2001; 91 965–71.
| PubMed |
[22] Rhodes SD, DiClemente RJ, Yee LJ, Hergenrather KC. Correlates of hepatitis B vaccination in a high-risk population: an internet sample. Am J Med 2001; 110 628–32.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[23] Yee LJ, Rhodes SD. Understanding correlates of hepatitis B virus vaccination in men who have sex with men: what have we learned? Sex Transm Infect 2002; 78 374–7.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[24] Anonymous . Future access to HIV vaccines. Report from a WHO-UNAIDS Consultation, Geneva, 2–3 October 2000. AIDS 2001; 15 W27–44.
| PubMed |
[25]
[26] Rhodes SD, Hergenrather KC. Exploring hepatitis B vaccination acceptance among young men who have sex with men: facilitators and barriers. Prev Med 2002; 35 128–34.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[27] Klitzman RL, Greenberg JD. Patterns of communication between gay and lesbian patients and their health care providers. J Homosex 2002; 42 65–75.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[28] McMahon E. The older homosexual: current concepts of lesbian, gay, bisexual, and transgender older Americans. Clin Geriatr Med 2003; 19 587–93.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[29] Neighbors K, Oraka C, Shih L, Lurie P. Awareness and utilization of the hepatitis B vaccine among young men in the Ann Arbor area who have sex with men. J Am Coll Health 1999; 47 173–8.
| PubMed |
[30] Barie PS, Dellinger EP, Dougherty SH, Fink MP. Assessment of hepatitis B virus immunization status among North American surgeons. Arch Surg 1994; 129 27–31.
| PubMed |
[31] Crossley KB, Gerding DN, Petzel RA. Acceptance of hepatitis B vaccine by hospital personnel. Infect Control 1985; 6 147–9.
| PubMed |
[32] Israsena S, Kamolratanakul P, Sakulramrung R. Factors influencing acceptance of hepatitis B vaccination by hospital personnel in an area hyperendemic for hepatitis B. Am J Gastroenterol 1992; 87 1807–9.
| PubMed |
[33] McGrane J, Staines A. Nursing staff knowledge of the hepatitis B virus including attitudes and acceptance of hepatitis B vaccination: development of an effective program. AAOHN J 2003; 51 347–52.
| PubMed |
[34] Rhodes SD, DiClemente RJ, Yee LJ, Hergenrather KC. Hepatitis B vaccination in a high risk MSM population: the need for vaccine education. Sex Transm Infect 2000; 76 408–9.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[35] Rhodes SD, Grimley DM, Hergenrather KC. Integrating behavioral theory to understand hepatitis B vaccination among men who have sex with men. Am J Health Behav 2003; 27 291–300.
| PubMed |
[36]
[37]
[38] Friedman MS, Blake PA, Koehler JE, Hutwagner LC, Toomey KE. Factors influencing a communitywide campaign to administer hepatitis A vaccine to men who have sex with men. Am J Public Health 2000; 90 1942–6.
| PubMed |
[39]
[40] Williams ML, Bowen AM, Horvath KJ. The social/sexual environment of gay men residing in a rural frontier state: implications for the development of HIV prevention programs. J Rural Health 2005; 21 48–55.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[41] Rhodes SD. Hookups or health promotion? An exploratory study of a chat room-based HIV prevention intervention for men who have sex with men. AIDS Educ Prev 2004; 16 315–27.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[42] Dufour A, Remis RS, Alary M, Otis J, Masse B, Turmel B, et al. Factors associated with hepatitis B vaccination among men having sexual relations with men in Montreal, Quebec, Canada. Omega Study Group. Sex Transm Dis 1999; 26 317–24.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[43] Rhodes SD, Yee LJ, Hergenrather KC. Hepatitis A vaccination among young African American men who have sex with men in the deep south: psychosocial predictors. J Natl Med Assoc 2003; 95 31S–6S.
| PubMed |
[44] Rhodes SD, Hergenrather KC. Using an integrated approach to understand vaccination behavior among young men who have sex with men: stages of change, the health belief model, and self-efficacy. J Community Health 2003; 28 347–62.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[45] Harrison AE, Silenzio VM. Comprehensive care of lesbian and gay patients and families. Prim Care 1996; 23 31–46.
| PubMed |
[46] Savage RB, Hussey MJ, Hurie MB. A successful approach to immunizing men who have sex with men against hepatitis B. Public Health Nurs 2000; 17 202–6.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[47] Samoff E, Dunn A, VanDevanter N, Blank S, Weisfuse IB. Predictors of acceptance of hepatitis B vaccination in an urban sexually transmitted diseases clinic. Sex Transm Dis 2004; 31 415–20.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[48] Cotter SM, Sansom S, Long T, Koch E, Kellerman S, Smith F, et al. Outbreak of hepatitis A among men who have sex with men: implications for hepatitis A vaccination strategies. J Infect Dis 2003; 187 1235–40.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[49] Rhodes SD, DiClemente RJ. Psychosocial predictors of hepatitis B vaccination among young African-American gay men in the deep south. Sex Transm Dis 2003; 30 449–54.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[50]
[51]
